TY - JOUR
T1 - Surgery for prosthetic valve endocarditis
T2 - 30th EACTS Annual Meeting
AU - Della Corte, Alessandro
AU - Di Mauro, Michele
AU - Dato, Guglielmo Actis
AU - Barili, Fabio
AU - Cugola, Diego
AU - Gelsomino, Sandro
AU - Sante, Pasquale
AU - Carozza, Antonio
AU - Della Ratta, Ester
AU - Galletti, Lorenzo
AU - Devotini, Roger
AU - Casabona, Riccardo
AU - Santini, Francesco
AU - Salsano, Antonio
AU - Scrofani, Roberto
AU - Antona, Carlo
AU - De Vincentiis, Carlo
AU - Biondi, Andrea
AU - Beghi, Cesare
AU - Cappabianca, Giangiuseppe
AU - De Bonis, Michele
AU - Pozzoli, Alberto
AU - Nicolini, Francesco
AU - Benassi, Filippo
AU - Pacini, Davide
AU - Di Bartolomeo, Roberto
AU - De Martino, Andrea
AU - Bortolotti, Uberto
AU - Lorusso, Roberto
AU - Vizzardi, Enrico
AU - Di Giammarco, Gabriele
AU - Marinelli, Daniele
AU - Villa, Emmanuel
AU - Troise, Giovanni
AU - Paparella, Domenico
AU - Margari, Vito
AU - Tritto, Francesco
AU - Damiani, Girolamo
AU - Scrascia, Giuseppe
AU - Zaccaria, Salvatore
AU - Renzulli, Attilio
AU - Serraino, Giuseppe
AU - Mariscalco, Giovanni
AU - Maselli, Daniele
AU - Parolari, Alessandro
AU - Nappi, Giannantonio
PY - 2017/7
Y1 - 2017/7
N2 - OBJECTIVES: We described clinical-epidemiological features of prosthetic valve endocarditis (PVE) and assessed the determinants of early surgical outcomes in multicentre design.METHODS: Data regarding 2823 patients undergoing surgery for endocarditis at 19 Italian Centers between 1979 and 2015 were collected in a database. Of them, 582 had PVE: in this group, the determinants of early mortality and complications were assessed, also taking into account the different chronological eras encompassed by the study.RESULTS: Overall hospital (30-day) mortality was 19.2% (112 patients). Postoperative complications of any type occurred in 256 patients (44%). Across 3 eras (1980-2000, 2001-08 and 2009-14), early mortality did not significantly change (20.4%, 17.1%, 20.5%, respectively, P = 0.60), whereas complication rate increased (18.5%, 38.2%, 52.8%, P <0.001), consistent with increasing mean patient age (56 +/- 14, 64 +/- 15, 65 +/- 14 years, respectively, P <0.001) and median logistic EuroSCORE (14%, 21%, 23%, P = 0.025). Older age, female sex, preoperative serum creatinine >-2 mg/dl, chronic pulmonary disease, low ejection fraction, non-streptococcal aetiology, active endocarditis, preoperative intubation, preoperative shock and triple valve surgery were significantly associated with mortality. In multivariable analysis, age (OR = 1.02; P = 0.03), renal insufficiency (OR = 2.1; P = 0.05), triple valve surgery (OR = 6.9; P = 0.004) and shock (OR = 4.5; P <0.001) were independently associated with mortality, while streptococcal aetiology, healed endocarditis and ejection fraction with survival. Adjusting for study era, preoperative shock (OR = 3; P <0.001), Enterococcus (OR = 2.3; P = 0.01) and female sex (OR = 1.5; P = 0.03) independently predicted complications, whereas ejection fraction was protective.CONCLUSIONS: PVE surgery remains a high-risk one. The strongest predictors of early outcome of PVE surgery are related to patient's haemodynamic status and microbiological factors.
AB - OBJECTIVES: We described clinical-epidemiological features of prosthetic valve endocarditis (PVE) and assessed the determinants of early surgical outcomes in multicentre design.METHODS: Data regarding 2823 patients undergoing surgery for endocarditis at 19 Italian Centers between 1979 and 2015 were collected in a database. Of them, 582 had PVE: in this group, the determinants of early mortality and complications were assessed, also taking into account the different chronological eras encompassed by the study.RESULTS: Overall hospital (30-day) mortality was 19.2% (112 patients). Postoperative complications of any type occurred in 256 patients (44%). Across 3 eras (1980-2000, 2001-08 and 2009-14), early mortality did not significantly change (20.4%, 17.1%, 20.5%, respectively, P = 0.60), whereas complication rate increased (18.5%, 38.2%, 52.8%, P <0.001), consistent with increasing mean patient age (56 +/- 14, 64 +/- 15, 65 +/- 14 years, respectively, P <0.001) and median logistic EuroSCORE (14%, 21%, 23%, P = 0.025). Older age, female sex, preoperative serum creatinine >-2 mg/dl, chronic pulmonary disease, low ejection fraction, non-streptococcal aetiology, active endocarditis, preoperative intubation, preoperative shock and triple valve surgery were significantly associated with mortality. In multivariable analysis, age (OR = 1.02; P = 0.03), renal insufficiency (OR = 2.1; P = 0.05), triple valve surgery (OR = 6.9; P = 0.004) and shock (OR = 4.5; P <0.001) were independently associated with mortality, while streptococcal aetiology, healed endocarditis and ejection fraction with survival. Adjusting for study era, preoperative shock (OR = 3; P <0.001), Enterococcus (OR = 2.3; P = 0.01) and female sex (OR = 1.5; P = 0.03) independently predicted complications, whereas ejection fraction was protective.CONCLUSIONS: PVE surgery remains a high-risk one. The strongest predictors of early outcome of PVE surgery are related to patient's haemodynamic status and microbiological factors.
KW - Early outcomes
KW - Infective endocarditis
KW - Prosthetic valve endocarditis
KW - Surgery
KW - Predictors
KW - INFECTIVE ENDOCARDITIS
KW - INTERNATIONAL-COLLABORATION
KW - EPIDEMIOLOGY
KW - MANAGEMENT
KW - MORTALITY
U2 - 10.1093/ejcts/ezx045
DO - 10.1093/ejcts/ezx045
M3 - Article
C2 - 28329161
SN - 1010-7940
VL - 52
SP - 105
EP - 111
JO - European Journal of Cardio-Thoracic Surgery
JF - European Journal of Cardio-Thoracic Surgery
IS - 1
Y2 - 1 October 2016 through 5 October 2016
ER -